Llwytho...

ADHD Medication Use Following FDA Risk Warnings

BACKGROUND: In 2006, the U.S. Food and Drug Administration (FDA) investigated cardiac and psychiatric risks associated with attention deficit/hyperactivity disorder (ADHD) medication use. AIMS OF THE STUDY: To examine how disclosure of safety risks affected pediatric ADHD use, and to assess news med...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Barry, Colleen L., Martin, Andres, Busch, Susan H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896970/
https://ncbi.nlm.nih.gov/pubmed/23001280
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!